1. Evenepoel P, D’Haese P, Brandenburg V. Sclerostin and DKK1: new players in renal bone and vascular disease. Kidney Int. 2015 Aug;88(2):235–40.
2. Bisson SK, Ung RV, Mac-Way F. Role of the Wnt/β-Catenin Pathway in Renal Osteodystrophy. Int J Endocrinol. 2018 Apr:5893514.
3. Mao B, Wu W, Davidson G, Marhold J, Li M, Mechler BM, et al. Kremen proteins are Dickkopf receptors that regulate Wnt/β-catenin signalling. Nature. 2002 Jun;417(6889):664–7..
4. Semënov M, Tamai K, He X. SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor. J Biol Chem. 2005 Jul;280(29):26770–5.
5. Keller H, Kneissel M. SOST is a target gene for PTH in bone. Bone. 2005 Aug;37(2):148–58.